Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

The pharmacology and clinical uses of tamoxifen.

Furr BJ, Jordan VC.

Pharmacol Ther. 1984;25(2):127-205. Review. No abstract available.

PMID:
6438654
2.

The agonistic and antagonistic properties of the high affinity antiestrogen--H1285.

Ruh TS, Ruh MF.

Pharmacol Ther. 1983;21(2):247-64. Review. No abstract available.

PMID:
6312469
3.
5.

Evolving concepts of selective estrogen receptor action: from basic science to clinical applications.

Smith CL, O'Malley BW.

Trends Endocrinol Metab. 1999 Oct;10(8):299-300. Review. No abstract available.

PMID:
10481159
6.
8.

Peptide antagonists of the human estrogen receptor.

Norris JD, Paige LA, Christensen DJ, Chang CY, Huacani MR, Fan D, Hamilton PT, Fowlkes DM, McDonnell DP.

Science. 1999 Jul 30;285(5428):744-6.

9.

Antioestrogens. A review.

Lunan CB, Klopper A.

Clin Endocrinol (Oxf). 1975 Sep;4(5):551-72. Review. No abstract available.

PMID:
170029
10.

Recent developments regarding steroid receptors and antihormones.

Baulieu E.

Maturitas. 1986 Jul;8(2):133-40. No abstract available.

PMID:
3747848
11.

Identification and biological activity of tamoxifen metabolites in human serum.

Kemp JV, Adam HK, Wakeling AE, Slater R.

Biochem Pharmacol. 1983 Jul 1;32(13):2045-52.

PMID:
6870933
12.

Antiestrogen pharmacology and mechanism of action.

Katzenellenbogen BS, Miller MA, Eckert RL, Sudo K.

J Steroid Biochem. 1983 Jul;19(1A):59-68.

PMID:
6887873
13.
14.

Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen.

Robertson DW, Katzenellenbogen JA, Long DJ, Rorke EA, Katzenellenbogen BS.

J Steroid Biochem. 1982 Jan;16(1):1-13. No abstract available.

PMID:
7062732
15.

Molecular determinants of tissue selectivity in estrogen receptor modulators.

Grese TA, Sluka JP, Bryant HU, Cullinan GJ, Glasebrook AL, Jones CD, Matsumoto K, Palkowitz AD, Sato M, Termine JD, Winter MA, Yang NN, Dodge JA.

Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):14105-10.

16.

Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines.

Westley B, May FE, Brown AM, Krust A, Chambon P, Lippman ME, Rochefort H.

J Biol Chem. 1984 Aug 25;259(16):10030-5.

17.
18.

Molecular mechanisms of resistance to tamoxifen therapy in breast cancer.

Morrow M, Jordan VC.

Arch Surg. 1993 Nov;128(11):1187-91. Review.

PMID:
8239980
19.

Antiestrogens inhibit the replication of the retroviral Moloney murine leukemia virus in vitro.

Chailleux C, Mesange F, Bayard F, Prats AC, Faye JC.

Mol Pharmacol. 1993 Aug;44(2):324-7.

PMID:
7689144
20.

Mechanisms of tamoxifen resistance.

Ring A, Dowsett M.

Endocr Relat Cancer. 2004 Dec;11(4):643-58. Review.

Supplemental Content

Support Center